MedTrace Logo

A Behavioral Application for Improving Smoking Cessation Among Smokers

NCT07493252 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1812

Last updated 2026-08-12

No results posted yet for this study

Summary

This clinical trial compares two smartphone applications, called Actify! (A \& B) for improving smoking cessation outcomes in individuals who smoke. Actify! A is an app grounded in behavioral activation therapy, an evidence-based treatment for depression that can also be used to modify health behaviors such as smoking. The Actify! B app provides evidence-based tobacco cessation strategies based on current clinical guidelines.

Conditions

  • Cigarette Smoking-Related Carcinoma

Interventions

BEHAVIORAL

Smartphone app-based Intervention (Actify! A app)

Use Actify! A app

BEHAVIORAL

Smartphone app-based Intervention (Actify! B app)

Use Actify! B app

OTHER

Health Promotion and Education

Receive motivational messages and smoking cessation information via text messages

OTHER

Survey Administration

Ancillary studies

Sponsors & Collaborators

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • Fred Hutchinson Cancer Center

    lead OTHER

Principal Investigators

  • Jaimee Heffner, PhD · Fred Hutch/University of Washington Cancer Consortium

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-11-01
Primary Completion
2029-07-31
Completion
2029-07-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07493252 on ClinicalTrials.gov